Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Seres Therapeutics (MCRB) Q2 2025 Earnings
MCRB
7
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.93
-1.37
1.19
3.75
Details
Expected EPS
0.102028
Actual EPS
3.75
Surprise EPS
3.65
Surprise Percent
+3,575.46%
Description
Seres Therapeutics (MCRB) has reported earnings of 3.75 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login